Novartis | NVS - Interest Income


Novartis reported $6M in Interest Income for its fiscal quarter ending in March of 2024.





Interest Income Change Date
AbbVie USD 67M 5M Jun/2026
AstraZeneca USD 80M 7M Jun/2026
Bausch Health Companies USD 13M 2M Sep/2026
Biogen USD 25.3M 12.6M Jun/2026
Canopy Growth CAD 3.23M 630K Jun/2026
Corcept Therapeutics USD 4.63M 255K Jun/2026
Drreddys Laboratories INR 919M 123M Sep/2026
Eli Lilly USD 65M 25M Sep/2025
Gilead Sciences USD 45M 50M Jun/2026
GlaxoSmithKline GBP 58M 36M Jun/2026
Glaxosmithkline GBP 29M 7M Sep/2026
J&J USD 0.09 2.18 Sep/2026
Merck USD 35M 0 Jun/2026
Pacira USD 1.94M 14K Jun/2026
Pfizer USD 0.56 0.6 Sep/2026
Phibro Animal Health USD 0.08 0.09 Dec/2024
Sanofi EUR 77M 17M Jun/2026
Sanofi EUR 77M 17M Jun/2026
Supernus Pharmaceuticals USD 2.63M 248K Jun/2026
Zoetis USD 16M 5M Jun/2026